Biontech Innovative Manufacturing Services GmbH

Biontech Innovative Manufacturing Services GmbH is an SME in Idar Oberstein, Germany that has taken part in 5 EU-funded projects since 2009, receiving €2.2M in EU funding.

EU funding received€2.2M
EU projects5
As coordinator0
Running now0
First EU project2009
Latest project2016
CountryGermany
EU registration (PIC)998097409
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Biontech Innovative Manufacturing Services GmbH's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.6M · 4 projects
  • Horizon 2020€550k · 1 project

Projects

5 EU-funded projects, newest first. Each links to the official record.

  • AML-VACCiNPartner

    Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

    Horizon 2020 · 2016–2020 · Project on CORDIS ↗

    €550ktheir share
  • NET4CGDPartner

    Gene Therapy for X-linked Chronic Granulomatous Disease (CGD)

    FP7 (2007 to 2013) · 2012–2018 · Project on CORDIS ↗

    €752ktheir share
  • GENEGRAFTPartner

    Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector

    FP7 (2007 to 2013) · 2011–2017 · Project on CORDIS ↗

    €516ktheir share
  • CELL-PIDPartner

    Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency

    FP7 (2007 to 2013) · 2010–2016 · Project on CORDIS ↗

    €50ktheir share
  • PERSISTPartner

    Persisting Transgenesis

    FP7 (2007 to 2013) · 2009–2013 · Project on CORDIS ↗

    €329ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • gene therapy
  • health care sciences
  • immunisation
  • immunology
  • immunotherapy
  • mutation
  • oncology
  • pharmaceutical drugs
  • stem cells
  • toxicology
  • transition metals
  • transplantation

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime